These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Cutaneous lymphoma: a clinically relevant classification. Pimpinelli N; Santucci M; Giannotti B Int J Dermatol; 1993 Oct; 32(10):695-700. PubMed ID: 8225705 [No Abstract] [Full Text] [Related]
25. [Definition, classification, clinical and histological diagnosis of cutaneous T-cell lymphomas]. Beylot-Barry M Ann Dermatol Venereol; 2005 Sep; 132 Spec No 2():5S5-10. PubMed ID: 16385891 [No Abstract] [Full Text] [Related]
26. Keratinocyte intracellular adhesion molecule-1 (ICAM-1) in the pathogenesis of Sezary syndrome and cutaneous T cell lymphoma. Fine RM Int J Dermatol; 1990 Nov; 29(9):623-4. PubMed ID: 2272733 [No Abstract] [Full Text] [Related]
27. Distinct subtypes of subcutaneous T-cell lymphoma. Burg G; Dummer R; Nestle F Arch Dermatol; 1994 Aug; 130(8):1073. PubMed ID: 8053710 [No Abstract] [Full Text] [Related]
28. Anti-KIR3DL2 therapy in the treatment of Sézary syndrome. Quaglino P Lancet Oncol; 2019 Aug; 20(8):1048-1049. PubMed ID: 31253571 [No Abstract] [Full Text] [Related]
29. Clinical research in cutaneous T-cell lymphoma moving forward. Sterry W; Heinzerling L Arch Dermatol; 2008 Jun; 144(6):786-7. PubMed ID: 18559771 [No Abstract] [Full Text] [Related]
30. Classification and prediction of survival in patients with the leukemic phase of cutaneous T cell lymphoma. Kari L; Loboda A; Nebozhyn M; Rook AH; Vonderheid EC; Nichols C; Virok D; Chang C; Horng WH; Johnston J; Wysocka M; Showe MK; Showe LC J Exp Med; 2003 Jun; 197(11):1477-88. PubMed ID: 12782714 [TBL] [Abstract][Full Text] [Related]
31. Rapid onset of CD8+ aggressive T-cell lymphoma during bexarotene therapy in a patient with Sézary syndrome. Kreuter A; Altmeyer P J Am Acad Dermatol; 2005 Dec; 53(6):1093-5. PubMed ID: 16310082 [No Abstract] [Full Text] [Related]
32. [Peripheral blood Sézary cells and the diagnosis of Sézary syndrome]. Tessier-Marteau A; Le Corre Y; Gérard J; Avenel-Audran M; Geneviève F; Verret JL; Zandecki M Ann Biol Clin (Paris); 2008; 66(4):447-53. PubMed ID: 18725348 [TBL] [Abstract][Full Text] [Related]
37. TCF1 and Tox define different subsets of CD4 T cells in patients with Sézary syndrome. Wysocka M; Jariwala N; Zhang K; Benoit B; Rook AH Leuk Lymphoma; 2022 Nov; 63(11):2715-2718. PubMed ID: 35679527 [No Abstract] [Full Text] [Related]
38. Neurolymphomatosis associated with Sézary syndrome. Bezier M; Reguiaï Z; Delaby P; Laroche L; Saïd G; Bernard P; Grange F Arch Dermatol; 2009 Mar; 145(3):294-6. PubMed ID: 19289760 [TBL] [Abstract][Full Text] [Related]
39. Two cases of syringotropic cutaneous T-cell lymphoma and review of the literature. Yost JM; Do TT; Kovalszki K; Su L; Anderson TF; Gudjonsson JE J Am Acad Dermatol; 2009 Jul; 61(1):133-8. PubMed ID: 19539851 [TBL] [Abstract][Full Text] [Related]
40. In vivo imaging of cutaneous T-cell lymphoma migration to the skin. Hoeller C; Richardson SK; Ng LG; Valero T; Wysocka M; Rook AH; Weninger W Cancer Res; 2009 Apr; 69(7):2704-8. PubMed ID: 19318575 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]